Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210.
Article
Google Scholar
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25.
Article
PubMed
PubMed Central
Google Scholar
Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109(9):1101–7.
Article
PubMed
Google Scholar
Wilmot KA, O’flaherty M, Capewell S, Ford ES, Vaccarino V. Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women. Circulation. 2015;132(11):997–1002.
Article
PubMed
PubMed Central
Google Scholar
Sidney S, Quesenberry CP, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol. 2016;1(5):594–9.
Article
PubMed
Google Scholar
Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mosca L, Barrett-Connor E, Kass WN. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011;124(19):2145–54.
Article
PubMed
PubMed Central
Google Scholar
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6.
Article
CAS
PubMed
Google Scholar
Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell. 2014;156(1):20–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine Rev. 2016;37(3):278–316.
Article
CAS
Google Scholar
Wills AK, Lawlor DA, Matthews FE, Sayer AA, Bakra E, Ben-Shlomo Y, et al. Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med. 2011;8(6):e1000440.
Article
PubMed
PubMed Central
Google Scholar
O’Keeffe LM, Simpkin AJ, Tilling K, Anderson EL, Hughes AD, Lawlor DA, et al. Sex-specific trajectories of measures of cardiovascular health during childhood and adolescence: a prospective cohort study. Atherosclerosis. 2018;278:190–6.
Article
PubMed
CAS
Google Scholar
O’Keeffe LM, Simpkin AJ, Tilling K, Anderson EL, Hughes AD, Lawlor DA, et al. Data on trajectories of measures of cardiovascular health in the Avon Longitudinal Study of Parents and Children (ALSPAC). Data in Brief. 2019;23:103687.
Article
PubMed
PubMed Central
Google Scholar
Link JC, Reue K. Genetic basis for sex differences in obesity and lipid metabolism. Ann Rev Nutr. 2017;37:225–45.
Article
CAS
Google Scholar
Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab. 2018;15:45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moran A, Jacobs DR Jr, Steinberger J, Steffen LM, Pankow JS, Hong C-P, et al. Changes in insulin resistance and cardiovascular risk during adolescence. Establishment of differential risk in males and females. Circulation. 2008;117(18):2361–8.
Article
CAS
PubMed
Google Scholar
Würtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum NMR metabolomics in large-scale epidemiology: a primer on-omic technology. Am J Epidemiol. 2017;186(9):1084–96. https://doi.org/10.1093/aje/kwx016.
Wang Q, Ferreira DLS, Nelson SM, Sattar N, Ala-Korpela M, Lawlor DA. Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC Med. 2018;16(1):17.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang Q, Würtz P, Auro K, Mäkinen V-P, Kangas AJ, Soininen P, et al. Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. BMC Med. 2016;14(1):205.
Article
PubMed
PubMed Central
Google Scholar
Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, et al. Cohort profile: the ‘children of the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2012;1:111–27.
Google Scholar
Northstone K, Lewcock M, Groom A, Boyd A, Macleod J, Timpson N, et al. The Avon Longitudinal Study of Parents and Children (ALSPAC): an update on the enrolled sample of index children in 2019. Wellcome Open Res. 2019;4:51. https://doi.org/10.12688/wellcomeopenres.15132.1.
Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, et al. Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol. 2013;42(1):97–110.
Article
PubMed
Google Scholar
Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192–206.
Article
CAS
PubMed
Google Scholar
Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med. 2012;172(22):1707–10.
Article
CAS
PubMed
Google Scholar
Cole TJ, Donaldson MD, Ben-Shlomo Y. SITAR—a useful instrument for growth curve analysis. Int J Epidemiol. 2010;39(6):1558–66.
Article
PubMed
PubMed Central
Google Scholar
Frysz M, Howe LD, Tobias JH, Paternoster L. Using SITAR (SuperImposition by Translation and Rotation) to estimate age at peak height velocity in Avon Longitudinal Study of Parents and Children. Wellcome Open Res. 2018;3:90. https://doi.org/10.12688/wellcomeopenres.14708.2.
Cole T, Pan H, Butler G. A mixed effects model to estimate timing and intensity of pubertal growth from height and secondary sexual characteristics. Ann Hum Biol. 2014;41(1):76–83.
Article
CAS
PubMed
Google Scholar
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop+ 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bell JA, Carslake D, O’Keeffe LM, Frysz M, Howe LD, Hamer M, et al. Associations of body mass and fat indexes with cardiometabolic traits. J Am Coll Cardiol. 2018;72(24):3142–54.
Article
PubMed
PubMed Central
Google Scholar
Würtz P, Wang Q, Kangas AJ, Richmond RC, Skarp J, Tiainen M, et al. Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med. 2014;11(12):e1001765.
Article
PubMed
PubMed Central
Google Scholar
Bull CJ, Bell JA, Murphy N, Sanderson E, Smith GD, Timpson NJ, et al. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study. medRxiv. 2020. https://doi.org/10.1101/2020.03.19.20031138.
Richardson TG, Mykkanen J, Pahkala K, Ala-Korpela M, Bell JA, Taylor K, et al. Evaluating the direct effects of childhood adiposity on adult systemic metabolism: a multivariable Mendelian randomization analysis. medRxiv. 2020. https://doi.org/10.1101/2020.08.25.20181412.
Sterne JA, Davey SG. Sifting the evidence—what’s wrong with significance tests? BMJ. 2001;322(7280):226–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wasserstein RL, Lazar NA. The ASA’s statement on p-values: context, process, and purpose. Am Statistician. 2016;70(2):129–33.
Article
Google Scholar
Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, et al. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2014;36(9):539–50.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ference BA, Majeed F, Penumetcha R, Flack JM, Brook RD. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2× 2 factorial Mendelian randomization study. J Am Coll Cardiol. 2015;65(15):1552–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713–22.
Article
CAS
PubMed
Google Scholar
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387–97.
Article
CAS
PubMed
Google Scholar
Ference BA, Kastelein JJ, Ginsberg HN, Chapman MJ, Nicholls SJ, Ray KK, et al. Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk. JAMA. 2017;318(10):947–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ference BA, Kastelein JJ, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, et al. Association of triglyceride-lowering LPL variants and LDL-C–lowering LDLR variants with risk of coronary heart disease. JAMA. 2019;321(4):364–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sniderman AD. Type III hyperlipoproteinemia: the forgotten, disregarded, neglected, overlooked, ignored but highly atherogenic, and highly treatable dyslipoproteinemia. Clin Chem. 2019;65(2):225–27. https://doi.org/10.1373/clinchem.2018.298026.
Sniderman A, Couture P, De Graaf J. Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. Nat Rev Endocrinol. 2010;6(6):335.
Article
CAS
PubMed
Google Scholar
Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45(11):1345.
Article
CAS
PubMed
PubMed Central
Google Scholar
Collaboration PS. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet. 2007;370(9602):1829–39.
Article
CAS
Google Scholar
Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet. 2012;380(9841):572–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012;367(22):2089–99.
Article
CAS
PubMed
Google Scholar
Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017;18(6):331.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Q, Holmes MV, Davey Smith G, Ala-Korpela M. Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation. Diab Care. 2017;40(12):1779–86. https://doi.org/10.2337/dc17-1642.
Perry JR, Murray A, Day FR, Ong KK. Molecular insights into the aetiology of female reproductive ageing. Nat Rev Endocrinol. 2015;11:725–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, et al. Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010;95(6):2560–75.
Article
PubMed
CAS
Google Scholar